Cannon Global Investment Management’s Terns Pharmaceuticals TERN Stock Holding History

Cannon Global Investment Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,000	Closed	-$474K	–	88
2026 Q1	$474K	Buy	+9,000	New	+$370K	0.93%	38

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cannon Global Investment Management's TERN Position: Q2 2026 in Review

Cannon Global Investment Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 9,000 shares — an estimated $474K sold.

Cannon Global Investment Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $474K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Cannon Global Investment Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Cannon Global Investment Management sold 9,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $474K.
Cannon Global Investment Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Cannon Global Investment Management's Terns Pharmaceuticals position peaked at $474K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Cannon Global Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.